~~<i id='39DE0F4E6F'><strike id='39DE0F4E6F'><tt id='39DE0F4E6F'><pre id='39DE0F4E6F'></pre></tt></strike></i>~~

Home» knowledge» Wikipedia

Wikipedia

author：knowledge 2025-09-28 22:42:44 Page View：94

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Vermont grapples with historic flooding as more rainstorms head for Northeast
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

2:45DemocraticpresidentialcandidateRobertF.KennedyJr.deliversaforeignpolicyspeechatSt.AnselmCollegei

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

J&J expands global access to TB drug amid advocacy campaign

ChrisO'Meara/APAdvocateshavebeenfightingJohnson&Johnsonforyearsoverapatentonalifesavingtube